Scar conditions and fibrosis of skin

L12_SCARCONDITIONS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L90.5 Hospital discharge: ICD-9 — 7092 Hospital discharge: ICD-8 — 7090[6-7] Cause of death: ICD-10 — L90.5 Cause of death: ICD-9 — 7092 Cause of death: ICD-8 — 7090[6-7] 2 out of 7 registries used, show all original rules.	1551
4. Check minimum number of events None	1551
5. Include endpoints None	1551
6. Filter based on genotype QC (FinnGen only)	1551

Control definitions (FinnGen only)

Control exclude: L12_OTHERSKINSUBCUTIS

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L90
Name in latin: Conditiones cicatricales et fibroses cutis

NAME	L12_SCARCONDITIONS
CONTROL_EXCLUDE	L12_OTHERSKINSUBCUTIS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L905
HD_ICD_9	7092
HD_ICD_8	7090[6-7]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L905
COD_ICD_9	7092
COD_ICD_8	7090[6-7]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Scar conditions and fibrosis of skin based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	10628	7098	3457
Only index persons	9929	6769	3160
Unadjusted period prevalence (%)
Whole population	0.17	0.20	0.10
Only index persons	0.21	0.25	0.12
Median age at first event (years)
Whole population	39.03	40.91	35.05
Only index persons	38.45	40.47	34.13

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1551	1168	383
Unadjusted period prevalence (%)	0.34	0.40	0.17
Median age at first event (years)	45.90	45.81	46.18

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1386: Matched controls
13861

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L90.5

ICD-10 Finland

Scar conditions and fibrosis of skin

13416.9

323.0

1191

L91.0

ICD-10 Finland

Hypertrophic scar

163.0

140.3

146

QAE20

NOMESCO Finland

Excision and repair of scar or web of skin of head or neck

170.0

119.4

124

7092A

ICD-9 Finland

Other disorders of skin and subcutaneous tissue, Scar conditions and fibrosis of skin

+∞

101.3

70907

ICD-8 Finland

Other diseases of skin, Cicatrix NUD

+∞

99.2

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

38.4

86.3

110

QBE30

NOMESCO Finland

Excision and repair of surgical scar in trunk

40.5

72.3

ZZF00

NOMESCO Finland

Graft of adipose tissue

25.0

61.4

ZXE10

NOMESCO Finland

More than one and less than three hours

2.5

53.4

614

3351

WX408

NOMESCO Finland

General anesthesy, balanced

2.6

50.7

480

2336

ZXE00

NOMESCO Finland

One hour or less

2.3

48.6

662

3883

ZXD10

NOMESCO Finland

Scheduled procedure

2.4

48.2

638

3681

L90.6

ICD-10 Finland

Striae atrophicae

462.3

45.5

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.6

45.2

401

1857

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

4.5

44.5

168

409

QBJ00

NOMESCO Finland

Liposuction in trunk

28.2

41.9

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.5

41.7

217

701

HAD30

NOMESCO Finland

Reduction mammoplasty with transposition of areola

5.5

41.3

129

255

QAE30

NOMESCO Finland

Excision and repair of surgical scar in head or neck

69.3

41.3

QDE20

NOMESCO Finland

Excision and repair of scar or web of skin of lower limb

113.5

41.0

Z3226

NOMESCO Finland

Physiotherapist

2.6

39.2

334

1494

HAD99

NOMESCO Finland

Other plastic operation on breast

24.4

38.2

ZZA00

NOMESCO Finland

Split skin graft

8.4

37.7

107

Z3231

NOMESCO Finland

Registered nurse

2.3

36.6

440

2344

Z2221

NOMESCO Finland

Medical doctor

2.2

35.4

472

2630

QCE20

NOMESCO Finland

Excision and repair of scar or web of skin of upper limb

78.2

34.0

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.8

33.6

154

445

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

3.6

33.5

160

479

9734

FHL

Excision and local plastic or associated free skin grafting

34.1

33.3

R4110

NOMESCO Finland

Physiotherapy

2.2

33.0

421

2283

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

3.7

32.5

150

436

N62

ICD-10 Finland

Hypertrophy of breast

4.4

32.1

122

297

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

5.4

30.8

189

QBJ30

NOMESCO Finland

Correction of abdominal apron

14.8

29.8

R4120

NOMESCO Finland

Occupational therapy

3.8

29.6

133

377

WX402

NOMESCO Finland

General anaesthesia

2.4

28.4

285

1364

ZXA00

NOMESCO Finland

Right side

2.1

27.9

394

2201

S18

ICPC

Laceration/cut

1.9

27.4

574

3738

ZXD20

NOMESCO Finland

Day surgery

2.5

26.0

237

1076

X59

ICD-10 Finland

Exposure to unspecified factor

2.3

26.0

286

1426

WX110

NOMESCO Finland

Local anesthesy

1.9

25.8

1002

8015

ZXA05

NOMESCO Finland

Left side

2.1

25.7

367

2051

N02AX02

ATC

tramadol; systemic, rectal

1.8

24.4

564

3761

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

23.7

535

3523

HA1AA

NOMESCO Finland

X-ray mammography

2.9

23.5

152

563

TQW99

NOMESCO Finland

Other minor procedure on skin

4.3

23.4

217

ZXA10

NOMESCO Finland

Bilateral

2.2

22.8

271

1392

N02BE01

ATC

paracetamol; systemic, rectal

2.1

22.4

1181

10207

J01DB01

ATC

cefalexin; oral

2.0

22.4

1141

9729

J02AC01

ATC

fluconazole; systemic

1.8

22.3

622

4366

WX002

NOMESCO Finland

Sedation and analgesia

2.1

22.2

294

1576

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

7.4

22.2

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

2.9

21.9

138

501

Z42.1

ICD-10 Finland

Follow-up care involving plastic surgery of breast

13.5

21.5

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

19.8

20.9

J01FF01

ATC

clindamycin; systemic

1.9

20.9

386

2352

ZXE20

NOMESCO Finland

More than three and less than five hours

2.3

20.5

200

934

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

20.0

520

3537

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

19.6

626

4516

N05CF01

ATC

zopiclone; oral

1.8

19.6

419

2669

HAE99

NOMESCO Finland

Other reconstruction of breast

10.8

19.5

N03AX16

ATC

pregabalin; oral

1.9

19.1

330

1953

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

18.9

369

2276

PJA12

NOMESCO Finland

Sentinel node biopsy

2.7

18.9

140

562

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

18.8

426

2762

N06AX11

ATC

mirtazapine; oral

1.8

18.6

439

2878

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

4.2

18.6

174

P01AB01

ATC

metronidazole; oral, rectal

1.7

18.3

567

4031

115

Kela drug reimbursment

Breast cancer

2.6

18.1

143

596

B01AB05

ATC

enoxaparin; parenteral

1.8

17.9

392

2504

TQW40

NOMESCO Finland

Remowal of suture of skin

2.8

17.9

118

442

ZZR00

NOMESCO Finland

Flap of skin

6.4

17.8

J01MA02

ATC

ciprofloxacin; systemic

1.7

17.8

483

3299

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.7

17.6

472

3208

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.1

17.6

219

1135

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

4.8

17.5

128

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

17.0

324

1973

QDE30

NOMESCO Finland

Excision and repair of surgical scar in lower limb

91.2

16.6

N05BA04

ATC

oxazepam; oral

1.8

16.2

348

2199

J01DA01

ATC

[U] cefalexin; systemic

1.6

16.1

834

6712

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.7

15.9

110

424

9733

FHL

Excision of skin change in operating room or anesthesia

6.5

15.9

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

4.8

15.8

115

ZXD05

NOMESCO Finland

Urgent procedure

1.7

15.6

419

2825

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

9.1

15.5

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

15.4

479

3366

A02BC02

ATC

pantoprazole; systemic

1.6

15.4

832

6734

X58

ICD-10 Finland

Exposure to other specified factors

2.1

15.3

195

1016

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

3.4

15.1

226

A02BC05

ATC

esomeprazole; systemic

1.6

15.1

533

3866

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.1

14.9

273

N05AH04

ATC

quetiapine; oral

1.9

14.7

241

1386

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

13.4

14.7

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

14.4

258

1531

L02BG04

ATC

letrozole; oral

2.6

14.3

110

451

J01FA10

ATC

azithromycin; systemic

1.6

14.2

813

6609

N06AX16

ATC

venlafaxine; oral

1.9

14.0

217

1223

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.7

14.0

382

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

3.1

14.0

252

SPAT1153

SPAT

Removal of sutures

1.7

13.9

391

2654

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

13.9

503

3654

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.1

13.6

171

886

QAE40

NOMESCO Finland

Repair of anomaly or lesion after disease of skin of head or neck

18.4

13.4

A02BC03

ATC

lansoprazole; oral

1.7

13.2

368

2485

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

2.6

13.2

395

HAC20

NOMESCO Finland

Total mastectomy

3.0

13.1

256

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

2.8

12.8

315

R03AC02

ATC

salbutamol; inhalant

1.5

12.8

702

5590

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

4.3

12.7

109

Z2446

NOMESCO Finland

Social worker

2.5

12.5

102

431

HAD20

NOMESCO Finland

Liposuction of breast

24.5

12.5

TQW11

NOMESCO Finland

Vacuum treatment of wound

5.7

12.4

M79.6

ICD-10 Finland

Pain in limb

1.6

12.4

460

3341

ZZR10

NOMESCO Finland

Flap of skin and muscle

9.1

12.3

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

5.2

12.2

Z2445

NOMESCO Finland

Psychologist

2.9

12.1

263

J01MA12

ATC

levofloxacin; systemic

1.8

12.0

215

1269

UJF32

NOMESCO Finland

Coloscopy

1.7

12.0

300

1962

Z71.8

ICD-10 Finland

Other specified counselling

1.6

11.9

332

2237

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

11.7

275

1767

WX320

NOMESCO Finland

Spinalanesthesy

1.7

11.6

282

1827

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.5

11.5

373

E0000UV

ATC

1.5

11.5

517

3906

L82

ICD-10 Finland

Seborrhoeic keratosis

1.9

11.5

165

902

N63

ICD-10 Finland

Unspecified lump in breast

2.4

11.4

101

447

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

4.4

11.3

N05CF02

ATC

zolpidem; oral

1.7

11.3

235

1453

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

11.1

642

5108

H02.3

ICD-10 Finland

Blepharochalasis

2.5

11.1

350

QAB10

NOMESCO Finland

Major dressing of wound of skin of head or neck

11.3

11.1

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

3.7

11.0

130

A02BA02

ATC

ranitidine; systemic

1.7

11.0

237

1479

L28

ICPC

Limited function/disability (L)

1.9

11.0

174

983

Z41.1

ICD-10 Finland

Other plastic surgery for unacceptable cosmetic appearance

9.3

11.0

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

4.6

11.0

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.0

11.0

144

760

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.4

10.9

429

M01AE01

ATC

ibuprofen; systemic, rectal

1.7

10.8

1220

11222

J02AC02

ATC

itraconazole; systemic

1.7

10.8

247

1573

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.5

10.8

355

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

10.7

960

8333

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

10.7

337

2335

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

4.0

10.6

104

ZZS45

NOMESCO Finland

Z-plasty

60.5

10.6

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

3.0

10.5

207

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

10.4

145

780

QCE30

NOMESCO Finland

Excision and repair of surgical scar in upper limb

+∞

10.4

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

10.4

495

3763

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.5

10.3

351

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

10.3

275

1820

W00

ICD-10 Finland

Fall on same level involving ice and snow

2.0

10.3

138

733

L02BA01

ATC

tamoxifen; oral

2.7

10.3

264

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

10.3

132

691

RD210

NOMESCO Finland

4.0

10.2

103

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.6

10.2

300

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.4

10.2

728

6005

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.3

10.2

398

L70.0

ICD-10 Finland

Acne vulgaris

3.1

10.1

173

QB2S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in chest

7.0

10.1

J01AA02

ATC

doxycycline; systemic

1.5

10.1

993

8726

HAD60

NOMESCO Finland

Replacement of prosthetic implant in breast

11.4

10.1

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.6

10.1

297

D10BA01

ATC

isotretinoin; oral

2.2

10.0

105

505

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.0

10.0

138

741

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

10.0

227

1438

ZXB10

NOMESCO Finland

Medial

9.6

9.8

WX290

NOMESCO Finland

Other blockade of nerve

1.4

9.7

593

4730

R01AD09

ATC

mometasone; nasal

1.4

9.7

605

4841

R06AE07

ATC

cetirizine; oral

1.4

9.7

585

4652

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.4

9.7

369

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

2.9

9.6

196

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

9.5

351

2517

J05AB01

ATC

aciclovir; systemic

1.6

9.5

271

1826

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

9.4

371

2696

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

9.4

669

5477

XQ848

NOMESCO Finland

Dermatological photography

3.8

9.4

101

ZQX00

NOMESCO Finland

0-4% of the skin

30.2

9.4

QDE35

NOMESCO Finland

Repair of skin defect in lower limb after surgery or injury

17.7

9.4

ZXC12

NOMESCO Finland

Pulse colorlaser

17.7

9.4

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.0

9.4

117

603

R51.80

ICD-10 Finland

Headache

1.7

9.4

206

1291

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

9.3

558

4418

N03AX12

ATC

gabapentin; oral

1.7

9.3

190

1166

HAD50

NOMESCO Finland

Removal of prosthetic implant from breast

8.7

9.3

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

3.0

9.2

184

M25.5

ICD-10 Finland

Pain in joint

1.5

9.2

364

2645

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.2

9.2

426

N06AB06

ATC

sertraline; oral

1.8

9.1

153

880

N06AB04

ATC

citalopram; systemic

1.6

9.1

276

1886

N06AA09

ATC

amitriptyline; systemic

1.9

9.1

131

715

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

4.6

9.1

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

9.1

175

1054

WX702

NOMESCO Finland

Supraglottic ventilation device

2.4

9.1

342

AA1AD

NOMESCO Finland

CT of head and brain

1.6

9.1

251

1673

R01AD08

ATC

fluticasone; nasal

1.5

9.1

369

2700

N06AX21

ATC

duloxetine; oral

1.8

9.1

147

837

M01AB05

ATC

diclofenac; systemic, rectal

1.4

9.0

855

7365

C07AA05

ATC

propranolol; systemic

1.6

9.0

266

1804

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

9.0

162

954

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

8.9

213

1368

Z3229

NOMESCO Finland

Other healthcare associate professional

2.0

8.9

107

545

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.9

8.9

131

723

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.7

8.9

184

1133

G44.2

ICD-10 Finland

Tension-type headache

1.7

8.8

187

1159

N06AB10

ATC

escitalopram; oral

1.6

8.8

275

1890

L57.0

ICD-10 Finland

Actinic keratosis

2.2

8.8

423

JN4BD

NOMESCO Finland

Extensive body CT

1.9

8.8

128

701

A46

ICD-10 Finland

Erysipelas

1.9

8.7

139

787

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.2

8.7

428

J01FA06

ATC

roxithromycin; oral

1.4

8.7

501

3922

Z42.2

ICD-10 Finland

Follow-up care involving plastic surgery of other parts of trunk

50.3

8.7

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

3.9

8.7

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

8.6

213

1376

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.4

8.6

749

6320

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.4

8.6

323

H03AA01

ATC

levothyroxine sodium; systemic

1.5

8.6

304

2149

D07AB08

ATC

desonide; topical

1.9

8.6

127

702

TQW20

NOMESCO Finland

Tatoe

4.8

8.6

D07AC01

ATC

betamethasone; topical

1.5

8.5

404

3045

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

5.0

8.5

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

8.4

344

2513

D06BB10

ATC

imiquimod; topical

2.5

8.4

262

H02AB06

ATC

prednisolone; systemic

1.4

8.4

553

4435

NGU20

NOMESCO Finland

Removal of internal fixation device from knee or lower leg

4.2

8.4

R52.2

ICD-10 Finland

Other chronic pain

2.8

8.4

196

ZX120

NOMESCO Finland

Intravenous

1.9

8.4

121

660

A02BC01

ATC

omeprazole; systemic

1.5

8.4

325

2346

M54.5

ICD-10 Finland

Low back pain

1.5

8.4

414

3146

TQB05

NOMESCO Finland

Puncture of skin of trunk

5.1

8.3

70906

ICD-8 Finland

Other diseases of skin, Cicatrix atrophica

+∞

8.3

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

3.5

8.3

108

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

4.2

8.3

N39.3

ICD-10 Finland

Stress incontinence

2.0

8.3

505

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

9.5

8.3

H02AB07

ATC

prednisone; oral

1.7

8.2

178

1108

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

8.2

516

4099

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

3.6

8.2

KMAK

NOMESCO Finland

1.4

8.2

686

5734

HAD40

NOMESCO Finland

Mastopexy

7.6

8.2

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

8.2

695

5823

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

2.4

8.1

293

K02.1

ICD-10 Finland

Caries of dentine

1.4

8.1

747

6343

ZZA50

NOMESCO Finland

Full thickness skin graft

11.8

8.1

RF210

NOMESCO Finland

3.0

7.9

146

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.7

7.9

159

970

J04AB02

ATC

rifampicin; systemic

6.1

7.9

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

3.4

7.9

108

ZY010

NOMESCO Finland

Hospital outpatient

2.3

7.8

327

QAA40

NOMESCO Finland

Laser therapy or photocoagulation of skin of head or neck

8.5

7.8

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

7.8

180

1142

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.3

7.8

309

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.2

7.7

330

J01AA07

ATC

tetracycline; systemic

1.6

7.7

198

1294

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.6

7.7

214

M01AX17

ATC

nimesulide; oral

1.5

7.7

274

1938

UJD02

NOMESCO Finland

Gastroscopy

2.5

7.7

233

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

7.6

289

2068

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.8

7.6

135

792

N64.9

ICD-10 Finland

Disorder of breast, unspecified

5.0

7.6

A03FA02

ATC

cisapride; oral, rectal

2.0

7.6

502

N06AX18

ATC

reboxetine; oral

5.2

7.6

L17

ICPC

Foot/toe symptom/complaint

1.5

7.5

292

2104

L90.0

ICD-10 Finland

Lichen sclerosus et atrophicus

5.5

7.5

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5.8

7.5

N06AB03

ATC

fluoxetine; oral

1.7

7.5

170

1071

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.6

7.5

212

K02.0

ICD-10 Finland

Caries limited to enamel

1.6

7.5

188

1221

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.4

7.5

260

N30.0

ICD-10 Finland

Acute cystitis

1.7

7.5

173

1101

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.1

7.5

418

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

7.5

300

2175

QA4S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in face

7.7

7.4

R60.0

ICD-10 Finland

Localized oedema

1.8

7.4

119

678

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

7.4

266

1883

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

7.4

167

1056

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

7.4

119

680

S29

ICPC

Skin symptom/complaint other

1.6

7.3

203

1351

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

3.1

7.3

120

R03AC03

ATC

terbutaline; inhalant

1.6

7.3

176

1132

QCD00

NOMESCO Finland

Dressing of major burn of upper limb

15.8

7.2

C50

ICD-10 Finland

Malignant neoplasm of breast

3.0

7.2

127

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.2

7.2

302

R50.9

ICD-10 Finland

Fever, unspecified

1.7

7.2

164

1040

N02AA05

ATC

oxycodone; systemic

1.7

7.2

141

855

N06AA10

ATC

nortriptyline; systemic

3.1

7.1

117

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

7.1

892

7887

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.8

7.1

122

712

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.0

7.1

433

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

8.8

7.1

M01AH05

ATC

etoricoxib; oral

1.4

7.1

732

6276

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

7.0

138

836

N05BA01

ATC

diazepam; systemic, rectal

1.7

7.0

162

1028

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

7.0

UKC02

NOMESCO Finland

Cystoscopy

1.7

7.0

146

903

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.9

7.0

526

C50.99

ICD-10 Finland

Breast, unspecified

2.8

7.0

147

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

6.9

104

576

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

2.1

6.9

352

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

5.5

6.9

HAE00

NOMESCO Finland

Reconstruction of breast using prosthesis

7.6

6.9

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.9

6.9

100

549

XF600

NOMESCO Finland

Bloodpressure measurement

2.1

6.9

367

R06.0

ICD-10 Finland

Dyspnoea

1.5

6.9

267

1921

R05

ICD-10 Finland

Cough

1.5

6.9

233

1627

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

6.9

285

2080

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.9

6.8

508

H02AB02

ATC

dexamethasone; systemic

1.8

6.8

126

748

R42

ICD-10 Finland

Dizziness and giddiness

1.5

6.8

231

1611

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

3.1

6.8

110

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

6.8

204

1384

G04BD04

ATC

oxybutynin; oral, transdermal

2.2

6.7

291

H53.1

ICD-10 Finland

Subjective visual disturbances

2.0

6.7

388

Z31.5

ICD-10 Finland

Genetic counselling

2.2

6.7

304

WZC30

NOMESCO Finland

Teaching

1.7

6.7

142

879

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.4

6.7

231

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.9

6.7

139

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.5

6.7

231

1620

X00

ICD-10 Finland

Exposure to uncontrolled fire in building or structure

22.6

6.7

QAB05

NOMESCO Finland

Revision of wound of skin of head or neck

22.6

6.7

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.5

6.6

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.3

6.6

254

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.1

6.6

360

N06AX12

ATC

bupropion; oral

1.9

6.6

470

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

3.7

6.6

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

2.2

6.6

280

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.7

6.6

145

908

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

6.5

122

727

QAB00

NOMESCO Finland

Suture of skin of head or neck

4.8

6.5

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

6.5

140

870

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.9

6.5

125

J01MA14

ATC

moxifloxacin; systemic

1.9

6.5

539

L02BG06

ATC

exemestane; oral

3.8

6.5

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

6.5

593

4962

EBB15

NOMESCO Finland

Insertion of dental implant abutment

5.7

6.5

T21.3

ICD-10 Finland

Burn of third degree of trunk

70.2

6.4

QAE35

NOMESCO Finland

Repair of skin defect in head or neck after surgery or injury

70.2

6.4

N06AX03

ATC

mianserin; oral

2.2

6.4

276

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.7

6.4

119

708

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

4.1

6.4

J01MA06

ATC

norfloxacin; oral

1.6

6.4

162

1054

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

6.4

165

1081

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.3

6.4

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

6.4

151

967

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

2.9

6.4

132

SBB00

NOMESCO Finland

Fotograf of mouth and teeth

2.3

6.3

258

HWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of mammary gland

8.2

6.3

R03DC03

ATC

montelukast; oral

1.5

6.3

205

1417

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.0

6.3

391

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

4.2

6.3

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

2.3

6.3

239

R22.4

ICD-10 Finland

Localized swelling, mass and lump, lower limb

3.0

6.3

111

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.6

6.3

155

1002

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

4.6

6.3

T90.5

ICD-10 Finland

Sequelae of intracranial injury

4.6

6.3

S01.9

ICD-10 Finland

Open wound of head, part unspecified

3.9

6.3

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.1

6.3

100

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

6.3

373

2904

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

6.3

200

1379

R03BA05

ATC

fluticasone; inhalant

1.5

6.3

226

1599

L91.8

ICD-10 Finland

Other hypertrophic disorders of skin

26.8

6.2

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.8

6.2

534

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.8

6.2

135

CBB20

NOMESCO Finland

Correction of lax skin of eyelid and resection of herniated fat

3.9

6.2

S97

ICPC

Chronic ulcer skin

2.5

6.2

177

A03DA02

ATC

pitofenone and analgesics; systemic

3.3

6.2

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

6.3

6.2

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

6.3

6.2

L84

ICD-10 Finland

Corns and callosities

3.2

6.2

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

3.4

6.1

E000002

ATC

1.6

6.1

139

880

L89

ICD-10 Finland

Decubitus ulcer and pressure area

12.6

6.1

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

6.1

121

736

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

6.1

128

795

D02AE01

ATC

carbamide; topical

1.9

6.1

427

RS230

NOMESCO Finland

8.6

6.1

QDB99

NOMESCO Finland

Other procedure for wound of skin of lower limb

8.6

6.1

R22.3

ICD-10 Finland

Localized swelling, mass and lump, upper limb

3.4

6.1

K05.1

ICD-10 Finland

Chronic gingivitis

1.9

6.1

487

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

6.0

182

1238

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

10.1

6.0

HAB40

NOMESCO Finland

Wedge excision of mammary gland

2.1

6.0

334

X21

ICPC

Breast sympt/compl female other

3.0

6.0

109

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

3.1

6.0

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.5

6.0

227

1620

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(40768804) Tissue Pathology biopsy report

768

5184

1.95

35.96

2.6

2.0

—

(3002256) Pathology report gross observation

323

1613

2.27

34.05

1.5

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

508

3059

1.98

32.45

6.0

3.4

95.2

94.2

0.42

497

2970

(3007853) Bacteria identified in Skin by Aerobe culture

273

1338

2.26

29.77

2.3

1.5

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1185

9624

1.98

28.18

9.0

6.9

u/l

75.1

76.4

0.61

1132

9055

(3015377) Calcium [Moles/volume] in Serum or Plasma

619

4127

1.83

27.98

4.4

3.3

mmol/l

2.4

0.33

553

3653

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

851

6296

1.78

26.64

7.0

5.7

umol/l

10.0

10.6

1.55

820

5959

(3024561) Albumin [Mass/volume] in Serum or Plasma

712

5006

1.78

26.53

5.8

4.4

g/l

36.3

36.2

0.16

665

4673

(3042936) Bacteria identified in Isolate by Culture

293

1579

2.05

24.71

2.4

1.8

—

(3044640) Blood type and Crossmatch panel - Blood

571

3869

1.75

23.38

2.7

2.2

—

(40758558) Short blood count panel - Blood

496

3247

1.78

22.77

9.2

6.4

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

212

1046

2.19

22.37

2.8

2.2

g/l

0.2

1.54

202

984

(3013650) Neutrophils [#/volume] in Blood by Automated count

939

7428

1.67

20.57

11.1

8.7

e9/l

3.9

4.0

0.44

836

6518

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

248

1378

1.95

18.81

3.4

2.5

umol/l

8.7

6.9

0.52

215

1175

(3013707) Erythrocyte sedimentation rate by Westergren method

1130

9485

1.70

18.79

4.6

3.9

mm/h

11.7

11.2

0.54

1059

8799

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

213

1123

2.04

18.75

2.5

2.1

u/l

31.7

38.7

1.23

190

949

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

777

5959

1.61

18.42

4.3

3.9

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

644

4765

1.60

17.43

2.1

1.9

pmol/l

96.3

96.5

0.03

330

2448

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

337

2114

1.76

17.22

3.1

2.8

mmol/l

2.4

0.22

285

1867

(4035726)

201

1075

2.00

16.93

1.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

756

5844

1.57

16.73

7.3

6.1

mmol/l

1.2

0.01

658

4944

(3012095) Magnesium [Moles/volume] in Serum or Plasma

293

1787

1.79

16.41

5.2

3.3

mmol/l

0.8

1.28

274

1676

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

205

1116

1.96

16.39

3.7

4.2

ug/l

3.4

23.4

1.93

153

896

(3018418) pH of Serum or Plasma

496

3488

1.62

16.32

4.8

3.5

7.4

0.36

651

(36304419) Bacteria [Presence] in Urine

458

3159

1.64

16.29

3.9

2.7

—

(3019069) Monocytes/100 leukocytes in Blood

771

6021

1.56

16.08

8.1

6.0

8.3

0.07

736

5654

(3006504) Eosinophils/100 leukocytes in Blood

766

5984

1.55

15.88

7.7

5.7

2.8

0.02

724

5575

(3018095) Leukocytes [#/volume] in Urine

578

4238

1.58

15.85

4.5

3.4

e6/l

51.4

97.1

1.66

418

2848

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

693

5303

1.55

15.70

6.6

5.4

mmol/l

1.2

0.24

639

4800

(42870588) Differential panel, method unspecified - Blood

568

4171

1.57

15.36

7.7

5.7

—

(3022096) Basophils/100 leukocytes in Blood

742

5785

1.54

15.32

7.8

5.8

0.7

0.57

703

5404

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

426

2923

1.63

15.32

2.5

2.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

766

6019

1.54

15.23

3.4

2.7

ug/l

94.9

94.8

0.00

717

5611

(3002030) Lymphocytes/100 leukocytes in Blood

787

6222

1.54

15.20

7.8

5.8

29.4

29.0

0.55

743

5818

(3002582) Erythrocytes [#/volume] in Urine

491

3500

1.59

15.02

4.0

2.9

e6/l

195.3

83.2

0.30

384

2626

(3052851) Hemolysis interference index of Serum or Plasma

345

2.61

14.93

3.6

3.0

—

(3048689) Calprotectin [Mass/mass] in Stool

282

1746

1.75

14.88

2.4

ug/g

98.1

113.6

0.57

221

1371

(3018010) Neutrophils/100 leukocytes in Blood

776

6134

1.53

14.88

7.6

5.6

56.1

56.5

0.46

736

5760

(3030467) Casts [#/volume] in Urine by Automated count

453

3181

1.60

14.71

4.0

2.8

e6/l

0.3

0.4

0.19

353

2340

(3013826) Glucose [Moles/volume] in Serum or Plasma

862

6995

1.52

14.44

4.9

4.3

mmol/l

6.4

6.5

1.83

812

6482

(3019550) Sodium [Moles/volume] in Serum or Plasma

1427

13117

2.10

14.32

18.2

13.0

mmol/l

139.6

139.7

0.85

1410

12767

(3023103) Potassium [Moles/volume] in Serum or Plasma

1430

13158

2.11

14.26

18.4

13.1

mmol/l

3.9

0.77

1410

12788

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

287

1809

1.72

14.15

3.6

2.6

e6/l

4.8

3.6

0.41

165

934

(3001604) Monocytes [#/volume] in Blood

793

6341

1.51

14.11

7.4

5.6

e9/l

0.6

0.61

677

5532

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

571

4269

1.53

13.90

3.8

3.0

u/l

31.4

30.5

0.29

544

4061

(3007164) IgA [Mass/volume] in Serum or Plasma

393

2699

1.61

13.87

1.6

1.5

g/l

2.4

2.2

0.63

224

1664

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

323

2112

1.67

13.87

4.7

3.4

ng/l

157.8

433.8

2.25

233

1469

(3044889) 12 lead EKG panel

1027

8696

1.54

13.76

3.9

3.3

—

(3006315) Basophils [#/volume] in Blood

793

6369

1.50

13.63

7.4

5.6

e9/l

0.0

0.05

681

5554

(3019198) Lymphocytes [#/volume] in Blood

811

6552

1.50

13.49

7.5

5.6

e9/l

2.0

1.9

0.30

706

5820

(3032080) INR in Blood by Coagulation assay

577

4345

1.52

13.48

7.4

inr

1.1

1.2

0.59

163

1352

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1415

13043

1.97

12.92

18.4

11.8

mg/l

21.6

21.4

0.07

1165

10099

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

196

2.98

12.80

1.3

1.6

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

295

1920

1.66

12.80

3.5

2.5

e6/l

0.7

1.0

1.86

170

1041

(3031040) Bacteria [#/volume] in Urine by Automated count

990

8378

1.50

12.80

5.3

4.1

e6/l

445.9

2319.0

1.23

112

(3013115) Eosinophils [#/volume] in Blood

811

6598

1.48

12.73

7.9

5.9

e9/l

0.2

0.14

710

5837

(3023368) Bacteria identified in Blood by Culture

406

2868

1.56

12.52

5.1

3.9

—

(1617658) Protocol used for examination of sentinel lymph nodes

131

3.43

12.52

1.0

—

(40768443) Skin Pathology biopsy report

433

2.30

12.49

1.4

1.2

—

(3025941) Bacteria identified in Stool by Culture

140

743

1.97

11.97

1.3

1.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

679

5378

1.47

11.95

2.8

2.2

nmol/l

77.3

76.3

0.37

628

4897

(3021589) Normoblasts [#/volume] in Blood

713

5711

1.46

11.79

11.3

8.5

e9/l

0.0

0.95

557

4689

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1182

10478

1.54

11.46

5.0

4.1

pmol/l

14.6

0.01

1106

9635

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1024

8817

1.47

11.43

3.4

2.9

u/l

44.6

42.1

0.38

972

8301

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

221

2.74

11.37

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

221

2.74

11.37

1.4

1.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

371

2619

1.55

11.32

1.6

1.5

nmol/l

22.0

21.2

0.38

309

2248

(3037467) Urinalysis macro (dipstick) panel - Urine

1018

8768

1.47

11.24

4.8

4.0

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

413

3000

1.51

11.00

2.3

2.1

mg/l

2.8

2.9

0.21

367

2560

(3022948) Iron [Moles/volume] in Serum or Plasma

267

1762

1.62

10.83

2.8

2.2

umol/l

14.2

13.8

0.36

250

1624

(3004789) Transferrin [Mass/volume] in Serum or Plasma

246

1592

1.65

10.79

2.7

2.2

g/l

2.4

0.52

223

1481

(3002385) Erythrocyte distribution width [Ratio]

1239

11152

1.55

10.66

22.5

14.6

13.6

0.54

1226

10904

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

229

1465

1.66

10.49

2.8

2.3

23.6

23.5

0.04

203

1250

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1327

12161

1.63

10.29

15.7

10.7

ml/min/173m2

87.7

85.3

3.65

1149

9898

(3014765) Yersinia sp identified in Stool by Organism specific culture

388

2.20

9.95

1.2

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

388

2.20

9.95

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

391

2.19

9.77

1.2

1.1

—

(3000494) Fungus identified in Specimen by Culture

222

1438

1.63

9.65

1.6

1.4

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

448

3390

1.45

9.49

2.3

2.0

u/l

173.6

212.5

0.51

431

3202

(3026782) Osmolality of Urine

314

2216

1.52

9.41

3.2

2.5

mosm/kgh2o

536.2

542.1

0.18

281

1876

(3000850) Epithelial cells [#/volume] in Urine

333

2385

1.50

9.29

3.0

2.3

e6/l

6.1

7.4

1.13

300

2083

(3000570) Elastase.pancreatic [Mass/mass] in Stool

344

2.21

9.02

1.4

ug/g

301.6

302.4

0.01

185

(3018677) aPTT in Platelet poor plasma by Coagulation assay

248

1682

1.56

8.86

4.4

2.0

30.8

29.5

2.58

240

1624

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1318

12170

1.55

8.64

6.0

4.9

mu/l

1.9

2.1

0.41

1255

11285

(3026008) Bacteria identified in Urine by Culture

480

3733

1.41

8.60

3.2

2.8

—

(36660697) Celiac disease serology panel - Serum

179

1131

1.66

8.55

1.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

385

2885

1.44

8.44

2.3

1.7

mg/l

1.0

0.03

296

2161

(3026493) Urate [Moles/volume] in Serum or Plasma

400

3024

1.43

8.35

2.8

2.3

umol/l

4071.3

4862.4

0.15

344

2628

(40761511) CBC panel - Blood by Automated count

1450

13738

1.85

8.33

15.0

11.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

329

2400

1.47

8.29

1.4

1.3

iu/ml

22.3

29.5

0.57

781

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

3.85

8.25

1.2

u/l

20.4

14.0

0.26

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

293

2.24

8.12

1.8

1.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

134

795

1.75

8.07

1.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

416

3196

1.41

7.87

1.4

1.3

u/ml

2.8

1.5

0.82

104

863

(3023323) Follitropin [Units/volume] in Serum or Plasma

137

829

1.72

7.69

1.4

iu/l

24.6

28.5

0.76

116

700

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

186

1218

1.60

7.69

1.9

1.6

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

367

2.07

7.69

4.5

2.4

187.4

174.1

0.46

354

(40768797) Stomach Pathology biopsy report

248

1736

1.51

7.61

1.3

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1455

13847

1.82

7.55

12.8

9.4

u/l

26.0

25.5

0.62

1427

13408

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

187

1232

1.59

7.53

2.0

1.7

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

129

773

1.73

7.50

2.1

2.2

ug/l

9.2

7.2

0.34

116

690

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

480

3808

1.38

7.43

2.7

2.4

u/l

57.8

56.3

0.45

462

3519

(3016650) Hepatitis A virus Ab [Presence] in Serum

206

2.37

7.10

1.1

—

(3022145) Colonoscopy Study observation

204

1396

1.53

6.94

1.4

1.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

114

2.85

6.86

1.1

1.2

u/l

63.3

55.4

0.55

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

134

839

1.65

6.64

2.8

3.2

u/ml

34.5

52.5

0.71

124

815

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

259

2.16

6.57

1.6

1.5

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

244

1752

1.47

6.56

2.0

1.7

—

(3019309) Folate [Moles/volume] in Red Blood Cells

268

1963

1.44

6.49

1.8

1.7

nmol/l

1077.6

1190.7

1.35

205

1488

(3003327) Ova and parasites identified in Stool by Light microscopy

459

1.85

6.34

1.7

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

142

913

1.61

6.33

6.4

6.6

mmol/l

1.3

0.55

137

875

(3024980) IgG subclass 4 [Mass/volume] in Serum

192

2.33

6.30

1.2

1.7

g/l

0.5

0.9

2.15

149

(3005719) IgG [Mass/volume] in Serum or Plasma

142

919

1.60

6.17

3.5

2.7

g/l

10.3

10.4

0.21

131

842

(3025130) Human papilloma virus identified in Specimen

220

2.22

6.14

1.7

1.8

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

366

2856

1.37

6.11

2.0

1.9

—

(3000991) Gas panel - Venous blood

134

858

1.61

6.08

10.6

7.6

—

(4010399)

133

851

1.62

6.06

1.5

1.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

332

1.97

5.94

3.7

2.0

ug/l

374.2

365.1

0.02

305

(3022217) INR in Platelet poor plasma by Coagulation assay

181

1249

1.51

5.92

20.3

20.6

inr

1.1

1.2

0.80

180

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

198

2.26

5.89

1.1

1.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

577

1.73

5.83

2.2

2.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

115

720

1.65

5.72

2.1

1.8

g/l

1.1

1.4

1.28

106

666

(3051611) Lipemic interference index of Serum or Plasma

116

2.62

5.57

3.7

3.0

—

(3036489) Thrombin time

473

1.77

5.50

4.3

2.0

23.0

20.8

1.38

412

(3037522) Nuclear Ab [Titer] in Serum

241

1785

1.41

5.45

1.5

1.3

titre

469.2

533.5

0.23

358

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

364

2886

1.34

5.40

1.7

1.6

—

(3021788) Differential panel - Synovial fluid

200

2.18

5.35

1.5

1.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

136

905

1.55

5.26

4.0

3.2

pmol/l

4.4

4.5

0.65

121

805

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1026

9341

1.29

5.23

3.5

3.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

505

1.72

5.16

2.4

1.8

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

123

804

1.58

5.15

3.1

2.8

ng/l

135.1

157.3

0.39

110

722

(3011397) Hemoglobin [Presence] in Urine by Test strip

360

2870

1.33

5.12

3.5

3.4

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

353

2809

1.33

5.08

3.3

2.8

ng/l

839.3

965.9

0.57

301

2320

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

164

1148

1.48

5.01

4.2

4.1

u/l

228.6

248.7

0.95

158

1091

(3035637) Corticotropin [Mass/volume] in Plasma

135

2.40

4.99

1.9

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

369

1.82

4.94

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

100

2.63

4.90

1.1

1.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

181

2.18

4.90

1.3

—

(3027945) Reticulocytes/100 erythrocytes in Blood

162

1138

1.47

4.86

3.6

2.8

1.7

1.8

0.49

148

1012

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

120

795

1.55

4.75

1.1

1.0

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

502

4223

1.28

4.73

3.4

3.2

ng/l

27.5

42.1

0.70

301

2569

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

217

1619

1.40

4.69

1.9

1.7

1.5

1.4

0.42

186

1451

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1226

11488

1.32

4.69

5.8

5.1

mmol/mol

38.5

39.0

1.49

1174

10724

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

294

2319

1.33

4.45

1.4

1.3

u/ml

11.0

11.7

0.06

104

941

(3003458) Phosphate [Moles/volume] in Serum or Plasma

194

1434

1.40

4.43

8.2

5.1

mmol/l

1.1

1.0

0.18

184

1318

(3028192) IgG subclass 2 [Mass/volume] in Serum

119

2.38

4.33

1.2

1.4

g/l

2.6

3.0

0.63

(3027135) IgG subclass 1 [Mass/volume] in Serum

119

2.38

4.33

1.2

1.4

g/l

8.6

6.9

0.62

(3024139) IgG subclass 3 [Mass/volume] in Serum

119

2.38

4.33

1.2

1.4

g/l

0.3

0.4

1.22

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

415

1.72

4.33

1.4

1.3

—

(3051651) Icteric interference index of Serum or Plasma

2.80

4.29

4.3

3.2

—

(3002032) Base excess in Venous blood by calculation

135

941

1.48

4.23

7.2

3.7

mmol/l

1.8

1.9

0.15

114

757

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

162

1170

1.43

4.22

3.7

2.9

—

(3021601) Nitrite [Presence] in Urine by Test strip

714

6320

1.24

4.21

5.3

4.6

estimate

0.0

0.50

136

1203

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

408

3393

1.27

4.13

1.6

1.7

mmol/l

1.4

0.54

355

2908

(3009261) Glucose [Presence] in Urine by Test strip

718

6371

1.24

4.10

3.7

3.4

estimate

0.0

0.80

134

1165

(3003396) Base excess in Arterial blood by calculation

159

1152

1.42

4.07

6.1

7.8

mmol/l

0.7

1.1

0.69

117

908

(3027944) Amphetamines [Presence] in Urine

636

1.56

4.06

2.1

1.9

—

(4062490)

123

2.30

4.05

1.2

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

1292

12264

1.32

4.01

20.8

12.9

39.8

0.05

1042

9339

(3017143) Hepatitis C virus Ab [Presence] in Serum

211

1608

1.36

4.01

1.7

1.5

—

(3000492) Spirometry study

173

1279

1.40

3.95

1.7

1.4

—

(3027008) Opiates [Presence] in Urine

642

1.54

3.90

2.2

2.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

135

958

1.45

3.88

1.7

1.8

—

(3028300) Cannabinoids [Presence] in Urine

645

1.54

3.83

2.2

1.9

—

(3035350) Ketones [Presence] in Urine by Test strip

706

6286

1.23

3.81

3.7

3.4

estimate

0.0

0.00

131

1188

(3000764) Benzodiazepines [Presence] in Urine

638

1.54

3.80

2.2

2.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

257

2036

1.31

3.75

2.5

2.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

116

807

1.47

3.70

1.5

1.4

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

157

1157

1.40

3.67

6.2

7.8

kpa

5.0

5.1

0.45

147

1100

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

233

1827

1.32

3.66

2.3

2.1

—

(3027801) Oxygen [Partial pressure] in Arterial blood

157

1158

1.40

3.65

6.2

7.8

kpa

12.9

12.4

0.37

147

1104

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

2.67

3.57

1.2

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

2.67

3.57

1.2

1.0

—

(3042733) HLA Ab [Presence] in Serum

3.86

3.52

3.5

5.0

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

409

1.64

3.52

1.5

2.0

g/l

1.5

0.06

359

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

2.49

3.47

5.6

6.5

—

(40768793) Breast Pathology biopsy report

372

1.67

3.46

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

201

1.91

3.45

1.8

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

253

1.80

3.40

1.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

131

950

1.41

3.37

6.8

8.7

g/l

122.5

121.2

0.33

123

913

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

204

1.88

3.32

1.2

u/ml

1.9

4.0

2.49

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

144

1065

1.39

3.31

1.2

iu/ml

154.1

144.7

0.10

419

(3006922) Hepatitis E virus Ab [Presence] in Serum

2.55

3.30

1.2

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1348

12951

1.31

3.24

5.0

4.5

mmol/l

2.8

0.58

1271

12050

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

121

874

1.42

3.19

4.7

3.7

ng/l

85.9

80.5

0.25

111

774

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.35

3.19

2.6

2.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

160

1218

1.35

3.09

2.0

1.9

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

299

1.69

3.08

3.7

2.8

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1330

12773

1.29

3.07

4.5

4.1

mmol/l

4.7

4.8

1.27

1256

11954

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

385

1.61

3.06

4.2

3.3

u/ml

32.7

3430.1

0.72

328

(3023511) Choriogonadotropin [Units/volume] in Urine

386

1.60

3.03

1.5

1.3

—

(3016502) Oxygen saturation in Arterial blood

137

1021

1.37

3.02

6.6

8.3

96.0

95.8

0.22

129

980

(3021901) Oxygen saturation in Capillary blood

161

1.94

3.00

2.1

2.4

—

(3044941) Cell count panel - Synovial fluid

176

1.89

2.97

1.6

1.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

542

1.50

2.96

6.9

10.8

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

526

1.51

2.95

2.8

2.0

u/l

42.8

39.2

0.79

470

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

237

1.75

2.87

1.4

u/ml

114.7

112.7

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

522

1.50

2.85

1.7

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

276

1.69

2.83

1.3

1.2

—

(3016879) Cocaine [Presence] in Urine

599

1.46

2.79

2.3

2.0

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

262

1.70

2.78

1.4

1.2

u/ml

258.9

229.3

0.20

149

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

285

1.67

2.78

11.2

3.1

u/ml

0.3

0.4

0.50

149

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

297

2485

1.24

2.78

1.6

1.7

pmol/l

26772119.7

27665039.4

0.01

254

2111

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

2.28

2.77

2.7

1.9

—

(3026361) Erythrocytes [#/volume] in Blood

1496

14665

1.57

2.77

26.2

17.7

e12/l

4.4

4.5

4.36

1478

14280

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

104

2.13

2.75

3.4

3.8

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

263

1.69

2.75

1.3

1.4

nmol/l

0.4

0.3

0.18

205

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

326

1.62

2.71

2.4

2.2

mg/l

11.2

11.1

0.06

302

(3010813) Leukocytes [#/volume] in Blood

1496

14669

1.56

2.71

26.3

17.7

e9/l

6.8

6.7

0.36

1478

14277

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

2.16

2.71

1.1

1.2

—

(1616796) Gas panel - Central venous blood

204

1.78

2.70

2.8

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

350

1.59

2.70

1.3

1.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

280

1.66

2.69

1.2

—

15.6

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

257

1.69

2.69

1.4

1.3

—

11.0

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

175

1.85

2.69

1.2

1.3

nmol/l

0.6

0.03

168

(3013139) Helicobacter pylori Ag [Presence] in Stool

119

886

1.37

2.67

1.3

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

2.34

2.65

1.6

1.5

u/l

7.7

6.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

614

1.44

2.65

1.6

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1274

12222

1.24

2.64

4.0

3.6

mmol/l

1.3

0.53

1180

11330

(3023520) Reticulocytes [#/volume] in Blood

112

828

1.38

2.63

3.4

2.6

e9/l

71.8

71.7

0.01

622

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

2.20

2.57

2.6

1.9

13.4

12.0

0.18

(3011288) Drugs identified in Urine by Screen method

436

1.51

2.55

3.2

2.8

—

(3023183) Ammonium ion [Moles/volume] in Plasma

193

1.78

2.55

3.5

3.1

umol/l

40.9

34.4

0.45

165

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

280

2350

1.23

2.54

1.6

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

2.51

2.53

2.8

u/ml

453.1

946.3

1.07

(3021879) Hepatitis B virus core Ab [Presence] in Serum

135

1035

1.33

2.52

1.5

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

325

1.59

2.51

2.7

2.3

g/l

0.2

0.7

1.29

290

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

123

931

1.35

2.50

4.4

3.2

mmol/l

1.2

0.70

110

801

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1317

12700

1.25

2.48

4.4

4.0

mmol/l

1.5

0.77

1233

11822

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

130

1.94

2.46

1.7

1.2

—

(3007461) Platelets [#/volume] in Blood

1493

14653

1.51

2.45

26.3

17.7

e9/l

263.1

258.8

1.79

1477

14299

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

376

1.54

2.43

2.0

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

376

1.54

2.43

2.0

g/l

7.6

7.4

0.37

290

(3034274) Bile acid [Moles/volume] in Serum --fasting

212

1.71

2.40

3.1

2.0

umol/l

5.6

5.9

0.04

152

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

5.01

2.40

1.8

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

266

1.63

2.40

1.3

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

509

1.46

2.39

1.2

u/ml

0.3

1.6

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

175

1.79

2.39

1.2

—

(1002224) Polysomnography panel

585

1.42

2.38

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

139

1.89

2.37

2.3

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

161

1.82

2.36

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

116

879

1.35

2.35

1.5

1.7

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

347

1.55

2.35

2.0

g/l

10.4

10.2

0.16

297

(40768441) Liver Pathology biopsy report

2.13

2.29

1.5

1.3

—

(4268621)

134

1.88

2.27

2.0

2.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

239

1.65

2.27

1.7

2.2

g/l

133.6

130.6

0.30

174

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

375

1.51

2.25

2.0

g/l

4.0

3.7

0.55

274

(3003694) ABO and Rh group [Type] in Blood

427

3776

1.18

2.22

1.5

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

2.20

2.21

1.8

1.3

umol/l

25.4

26.8

0.06

(40760892) CBC W Ordered Manual Differential panel - Blood

344

2987

1.19

2.20

4.9

4.1

—

(3024471) HLA-A [Type]

2.79

2.20

1.0

—

(3005322) IgE [Units/volume] in Serum or Plasma

117

899

1.33

2.18

1.4

1.2

u/ml

150.7

212.6

0.77

107

832

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

2.17

2.15

1.3

1.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

357

1.50

2.09

2.1

g/l

3.2

3.1

0.28

280

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

696

1.36

2.07

2.5

2.2

u/l

6817.1

4345.1

0.19

275

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

122

951

1.31

2.07

2.5

2.4

ml/min/173m2

75.3

71.3

0.49

358

(3011412) CD3 cells [#/volume] in Blood

110

1.92

2.06

2.4

2.3

e9/l

1.2

0.03

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1.99

2.05

1.5

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

207

1.66

2.05

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

294

1.55

2.04

3.1

2.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

4.01

2.04

1.8

1.7

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

111

1.90

2.01

2.9

1.6

—

(3034426) Prothrombin time (PT)

2.64

2.01

1.0

1.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

648

1.36

2.01

2.2

2.1

nmol/l

10.1

12.2

1.51

576

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.01

2.00

1.8

1.2

—

(21494815) CD4 cells/100 lymphocytes in Specimen

104

1.94

2.00

2.8

2.1

—

43.8

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

1.97

2.00

1.4

1.5

umol/l

8.8

11.2

1.37

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

116

1473

0.77

1.98

4.6

4.2

31.0

32.2

0.62

1018

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.99

1.95

1.8

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

406

3610

1.17

1.95

3.4

3.0

mmol/l

7.6

7.5

0.03

340

3058

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.97

1.93

1.5

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

188

1.66

1.91

2.1

1.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

671

1.35

1.91

2.4

2.3

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

2.06

1.91

2.5

2.4

e9/l

0.2

0.12

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

374

1.46

1.89

1.9

2.1

ug/l

4.1

2.0

0.39

338

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

2.32

1.88

2.6

1.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

2.32

1.88

2.6

1.8

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

501

1.39

1.87

2.1

2.0

—

(4306422)

197

1.64

1.87

1.1

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

2.21

1.84

1.3

—

927.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

206

1.62

1.83

1.1

1.0

u/ml

3.2

1.7

0.54

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

101

1.89

1.81

1.8

1.3

—

(3023420) DNA double strand Ab [Units/volume] in Serum

131

1.77

1.78

1.7

1.5

—

19.7

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.91

1.75

1.4

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.91

1.75

1.4

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.91

1.75

1.4

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.91

1.75

1.4

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.91

1.75

1.4

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

1.94

1.75

1.2

1.1

iu/ml

3.3

13.7

—

(3016018) Differential panel - Cerebral spinal fluid

117

1.81

1.74

1.9

1.8

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1282

12427

1.18

1.74

4.7

4.1

mmol/l

5.8

0.10

1205

11448

(3024932) HLA-DR beta [Type]

2.51

1.74

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

622

1.34

1.72

1.5

—

(3024928) Oxygen saturation in Venous blood

226

1.56

1.71

4.7

4.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.89

1.71

1.4

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

2.01

1.69

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

1.96

1.69

2.4

e6/l

585.4

473.6

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

141

1.71

1.68

5.1

4.3

u/ml

190.0

48.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

104

1.84

1.67

1.6

2.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

188

1.61

1.66

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

326

1.46

1.66

1.1

1.2

u/ml

3.7

7.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

402

1.41

1.65

1.6

1.4

u/l

12.2

10.2

0.35

324

(40757373) Influenza virus identified in Isolate

2.81

1.65

1.7

1.4

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

2.04

1.64

1.6

1.4

nmol/l

28.3

32.2

0.22

(3026389) Candida sp identified in Specimen by Organism specific culture

173

1.63

1.64

1.5

1.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

104

823

1.28

1.62

2.6

2.7

g/l

65.9

67.1

0.73

753

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

104

823

1.28

1.62

1.3

au/ml

29.0

42.9

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

2.15

1.61

1.3

—

54.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

151

1.67

1.60

1.2

nmol/l

—

(4198724)

2.07

1.60

1.3

2.0

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

630

1.32

1.59

5.3

8.3

mmol/l

24.5

24.6

0.05

580

(4094501)

313

1.45

1.58

1.0

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.70

1.58

1.4

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

264

1.49

1.57

1.5

1.6

e6/l

22275.0

12255.4

0.30

200

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

395

0.63

1.53

1.6

1.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

366

1.41

1.52

1.2

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

3.34

1.52

1.0

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

3.34

1.52

1.0

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

1.51

0.0

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

479

1.35

1.50

1.3

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

113

914

1.25

1.49

2.4

au/ml

23.8

23.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.44

1.48

2.1

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.23

1.46

1.7

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

3.13

1.44

1.2

1.1

—

(3037121) Protein [Mass/volume] in Urine

397

1.37

1.42

3.4

3.2

g/l

0.4

0.3

0.74

155

(3014133) Dog dander IgE Ab [Units/volume] in Serum

226

0.53

1.42

1.0

u/ml

11.8

3.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

221

1.50

1.41

13.3

5.1

iu/ml

222.4

354.6

—

(3014051) Protein [Presence] in Urine by Test strip

305

1.42

1.39

1.7

1.9

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

662

1.28

1.39

3.5

3.6

kpa

5.2

5.1

0.22

622

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

214

1.51

1.38

1.2

u/ml

7.0

3.0

0.36

(3021387) Prolactin [Units/volume] in Serum or Plasma

600

1.30

1.38

1.8

1.6

mu/l

313.8

314.3

0.00

539

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.01

1.38

2.8

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

595

0.71

1.38

1.2

1.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.20

1.37

2.6

1.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.95

1.36

2.4

1.4

—

(3017509) Phencyclidine [Presence] in Urine

2.95

1.36

1.8

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

390

3545

1.13

1.35

3.2

2.9

—

(3009343) pH of Capillary blood

656

1.28

1.35

3.4

3.6

7.4

0.85

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.04

1.33

1.4

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.51

1.30

1.0

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

1.77

1.29

1.6

1.4

promille

1.0

1.2

0.27

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

2.78

1.28

1.0

nmol/l

3.8

4.3

—

(3010421) pH of Blood

277

1.42

1.27

3.0

2.7

7.4

1.38

223

(40767503) Oxygen content in Capillary blood by calculation

194

1.50

1.27

2.4

2.1

17.2

16.4

0.55

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

635

1.27

3.3

3.6

mmol/l

2.4

1.7

1.05

476

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.29

1.27

1.3

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

2.05

1.27

1.8

1.7

—

(3025159) Blasts/100 leukocytes in Blood

112

925

1.23

1.26

4.4

4.0

0.0

0.4

0.58

202

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

278

1.41

1.25

1.3

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.23

1.24

2.0

2.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

179

1.52

1.24

2.6

1.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

254

1.43

1.22

2.4

1.6

—

(3000330) Specific gravity of Urine by Test strip

576

1.28

1.22

3.0

2.9

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.05

1.22

2.9

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.05

1.22

2.4

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.80

1.21

1.4

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

375

1.34

1.20

2.5

1.9

iu/l

9.2

4.8

0.37

138

(3004809) Band form neutrophils/100 leukocytes in Blood

165

1.52

1.18

2.6

3.4

0.8

1.1

0.46

132

(3012516) Albumin [Mass/volume] in Urine

353

3218

1.13

1.17

3.4

3.2

mg/l

240.1

366.7

0.28

216

1959

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.01

1.16

2.9

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

257

1.41

1.16

2.3

1.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

386

1.33

1.16

1.4

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

1.69

1.14

2.0

1.8

—

(3019060) Gas panel - Arterial blood

656

1.25

1.11

3.4

6.2

—

(44790047)

135

1.56

1.11

2.0

1.4

—

(44790049)

135

1.56

1.11

2.0

1.4

—

(44790048)

135

1.56

1.11

2.0

1.4

—

(44806118)

135

1.56

1.11

2.0

1.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

112

939

1.21

1.11

4.1

3.7

0.5

0.6

0.15

189

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

226

1.42

1.10

1.7

1.6

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

416

1.31

1.10

3.4

7.3

2.0

1.6

0.89

385

(3017732) Neutrophils [#/volume] in Blood

105

878

1.21

1.08

2.8

e9/l

4.1

0.03

716

(3049717) Cytology report of Urine Cyto stain

330

1.34

1.08

2.2

2.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

400

1.31

1.07

1.5

1.6

iu/ml

0.0

0.1

0.16

(3027456) Digoxin [Moles/volume] in Serum or Plasma

169

1.49

1.07

2.3

3.2

nmol/l

0.9

0.8

0.21

138

(3007930) Methemoglobin/Hemoglobin.total in Blood

409

1.31

1.07

3.4

7.4

1.0

0.9

0.30

377

(3038177) Helicobacter pylori Ab [Presence] in Serum

236

1.41

1.07

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

271

1.37

1.05

1.5

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.71

1.05

2.0

1.5

—

(3017181) Myelocytes/100 leukocytes in Blood

121

1029

1.19

1.05

4.8

3.9

0.8

0.9

0.16

263

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.28

1.03

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.28

1.03

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.28

1.03

1.0

—

(40758292) HTLV I+II Ab panel - Serum

2.28

1.03

1.0

1.5

—

(3039000) Anion gap in Blood

238

1.39

1.03

3.3

10.8

mmol/l

10.7

11.3

0.45

211

(3020682) Albumin/Creatinine [Ratio] in Urine

367

3380

1.11

1.02

4.2

3.8

mg/mmol

9.8

8.2

0.22

212

2061

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

312

2848

1.12

1.01

1.6

1.4

—

(3018572) Chloride [Moles/volume] in Blood

239

1.39

1.01

3.3

10.8

mmol/l

104.3

105.3

0.79

212

(3008295) Osmolality of Serum or Plasma

124

1.54

0.97

1.5

1.4

mosm/kgh2o

280.7

279.8

0.08

(40768795) Lymph node Pathology biopsy report

116

1.56

0.96

1.1

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

311

1.33

0.95

1.4

1.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

1.69

0.95

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

141

1.50

0.95

1.1

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

251

1.36

0.94

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

251

1.36

0.94

1.1

—

(3047181) Lactate [Moles/volume] in Blood

347

1.31

0.94

3.6

8.7

mmol/l

1.6

1.3

0.38

299

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.73

0.92

1.6

2.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

218

1.38

0.91

1.2

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

1.67

0.91

1.2

1.3

u/l

5.5

6.7

0.55

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

143

1.47

0.90

1.1

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

211

1.38

0.88

1.3

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

1.65

0.88

1.8

1.3

e6/l

46580.0

37483.6

—

(3006653) Thiamine [Moles/volume] in Blood

1.79

0.88

1.8

1.5

nmol/l

134.9

137.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

144

1.46

0.87

2.7

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

517

4879

1.09

0.86

3.8

3.4

—

(3045424) Erythrocytes [Presence] in Urine

216

0.64

0.86

1.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

213

1.37

0.84

3.5

2.3

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

1.78

0.84

2.4

4.0

—

26.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.76

0.83

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

432

0.76

0.82

1.4

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

105

1.53

0.81

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.71

0.80

1.0

—

(3017704) Immunofixation for Urine

1.73

0.79

1.5

1.7

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

190

1.37

0.79

1.1

—

(3024263) Appearance of Synovial fluid

1.67

0.78

1.1

1.7

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.00

0.78

0.0

2.5

—

(3012501) Base excess in Blood by calculation

225

1.34

0.78

3.2

2.8

mmol/l

2.7

2.6

0.11

150

(3022621) pH of Urine by Test strip

807

1.18

0.78

2.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.77

0.76

1.0

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

132

1.44

0.76

1.6

1.7

32.8

32.1

0.32

132

(3013512) EKG study

351

3276

1.09

0.75

3.8

3.4

—

(3045142) Bone marrow Pathology biopsy report

124

1.46

0.75

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.60

0.75

1.1

1.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

112

980

1.15

0.74

4.3

3.9

0.1

0.17

239

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.85

0.73

2.1

1.2

—

(1761868) Lipid panel - Serum or Plasma

514

4883

1.08

0.72

2.6

—

(3012441) Differential panel - Pleural fluid

1.58

0.71

1.8

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

134

1.42

0.71

2.2

1.4

—

(3028433) Virus identified in Specimen by Culture

1.75

0.71

1.3

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

194

0.67

0.71

1.3

1.4

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.93

0.70

1.0

1.2

—

(21494434) Karyotype in Bone marrow

1.51

0.69

1.1

1.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

1.53

0.69

2.4

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

110

1.46

0.68

1.0

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

110

1.46

0.68

1.3

1.9

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

153

1.38

0.67

2.3

2.5

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

1.62

0.65

1.1

—

9.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

163

1.35

0.64

2.2

1.4

—

(3005570) Glucose [Moles/volume] in Urine

129

0.62

0.64

1.9

2.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.73

0.64

1.2

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

102

0.59

0.62

1.5

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

105

0.57

0.61

1.0

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

175

1598

1.11

0.61

4.4

4.0

17.9

21.0

2.34

706

(3027273) Bicarbonate [Moles/volume] in Venous blood

453

1.20

0.61

4.4

3.0

mmol/l

25.6

25.4

0.19

439

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.60

0.61

1.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.60

0.0

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

174

1.33

0.60

1.4

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.59

0.0

2.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.59

0.0

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

210

1.29

0.59

1.4

1.3

—

(3006462) Nitrate [Presence] in Urine

1.51

0.58

1.9

2.5

—

(3029075) Extractable nuclear Ab panel - Serum

1.72

0.57

1.0

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

264

0.75

0.57

1.0

1.1

u/ml

3.1

3.4

—

(3051593) INR in Capillary blood by Coagulation assay

1.67

0.56

15.7

8.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.57

0.56

2.6

2.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.62

0.55

1.2

1.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

403

1.20

0.55

1.1

u/ml

3.8

3.6

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

441

1.19

0.54

3.4

3.9

mmol/l

25.1

24.9

0.22

416

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.58

0.54

1.2

1.1

—

(4211845)

1.50

0.54

1.9

2.4

—

(3018405) Lactate [Moles/volume] in Arterial blood

350

1.21

0.53

3.6

3.8

mmol/l

1.4

1.3

0.08

345

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.43

0.52

1.0

1.1

miu/ml

1718.8

1687.7

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

197

1.27

0.51

5.4

5.7

umol/l

302.1

382.2

2.24

168

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

216

2014

1.08

0.50

4.9

4.5

ug/l

2.3

2.2

0.04

197

1811

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

1.47

0.50

3.0

1.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

180

1666

1.09

0.50

1.7

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.50

0.49

1.2

1.4

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

101

1.39

0.49

1.5

1.4

g/l

1.0

0.02

101

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

136

1.33

0.49

1.1

—

(3004451) EKG impression Narrative

1.56

0.49

1.3

1.2

—

(3047189) Immunofixation for 24 hour Urine

1.56

0.49

1.3

1.9

—

(3044290) Cell count panel - Cerebral spinal fluid

262

1.23

0.48

1.8

1.7

—

(3045414) Leukocytes [Presence] in Urine

588

1.15

0.47

1.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

245

1.23

0.47

2.1

2.5

ug/min

24.3

98.3

1.81

156

(3035880) pH of Pleural fluid

1.46

0.46

1.3

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

331

0.81

0.46

1.4

1.5

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.43

0.46

1.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

582

1.14

0.45

1.9

1.7

mg/l

7.1

4.4

0.42

411

(4034850)

427

0.84

0.44

15.1

8.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

173

1610

1.08

0.44

1.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

140

1.29

0.42

1.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

139

0.72

0.42

1.0

1.1

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.41

0.0

1.3

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.40

0.0

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.47

0.40

1.6

3.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.47

0.40

1.6

3.0

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.47

0.40

1.2

1.3

pmol/l

369.4

327.6

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.47

0.40

2.4

1.9

—

(3022313) Gas panel - Capillary blood

493

1.14

0.40

3.5

3.8

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.37

0.40

1.3

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

124

1.29

0.38

1.7

1.6

—

(3042631) Mycobacterium sp identified in Specimen

133

1.28

0.38

2.6

2.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

142

1.27

0.38

1.1

1.4

pmol/l

447.8

323.4

0.64

110

(3019150) Specific gravity of Urine by Refractometry

288

2747

1.06

0.38

4.0

3.8

kg/l

1.0

0.11

383

(40761536) Microorganisms panel - Urine sediment

120

1109

1.09

0.37

4.0

3.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

1.33

0.37

2.4

2.8

52.9

56.8

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

526

1.13

0.36

1.3

miu/ml

220.7

225.9

0.04

266

(3029937) Albumin [Presence] in Urine by Test strip

322

3357

0.95

0.36

4.1

3.6

estimate

0.0

1.08

132

1179

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

593

1.12

0.36

1.5

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

101

929

1.09

0.35

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.37

0.34

1.2

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.37

0.34

1.2

1.5

—

(3008898) HLA-B27 [Presence]

548

1.12

0.34

1.0

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

165

1553

1.07

0.34

1.8

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

1.32

0.33

2.3

2.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.31

0.33

1.0

1.3

—

(3014271) Vancomycin [Susceptibility]

1.31

0.33

2.8

2.2

—

(4027681)

0.67

0.32

1.3

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.33

0.32

1.5

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

130

1385

0.93

0.30

7.0

5.7

—

(3045788) Cell count panel - Pleural fluid

1.34

0.30

2.0

1.3

—

(44813793)

102

1.28

0.30

1.0

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

401

1.13

0.29

1.8

1.6

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

1.25

0.29

1.3

1.1

u/l

11.0

11.8

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

421

1.12

0.28

5.9

3.4

51.9

49.3

0.30

416

(21494755) Public health laboratory ask at order entry panel

137

1452

0.94

0.28

1.3

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

151

0.79

0.28

1.1

—

(3020891) Body temperature

385

1.12

0.27

4.5

4.4

—

(3044927) Protein electrophoresis panel - Urine

104

1.25

0.26

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

443

1.11

0.26

1.9

1.8

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

253

1.15

0.26

4.4

3.3

mg/l

25.4

22.7

0.14

154

(3004119) Hemoglobin [Mass/volume] in Venous blood

607

1.09

0.26

4.6

3.4

g/l

126.6

128.6

0.37

594

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

282

1.14

0.25

1.4

1.7

nmol/l

44.0

40.2

0.27

271

(40760888) Immunoglobulin light chains.free panel - Serum

216

1.16

0.25

3.8

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.20

0.25

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

588

0.92

0.23

1.2

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

897

0.93

0.23

1.4

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.28

0.23

1.0

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.28

0.23

1.2

1.4

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

1.28

0.23

1.0

1.2

—

16.8

—

(3005033) Fetal Nuchal fold Thickness US

390

1.11

0.23

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

525

0.91

0.23

1.7

1.9

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.22

0.22

1.0

1.1

—

(3020650) Glucose [Presence] in Urine

1.22

0.22

1.0

1.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

135

0.81

0.22

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.19

0.21

2.4

1.8

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

1.19

0.21

2.2

2.4

mg/l

7.9

11.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.21

0.0

2.7

—

(3026726) Creatinine [Moles/volume] in Specimen

0.00

0.21

0.0

2.0

—

327.3

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

12.7

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.21

0.0

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.21

0.0

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

392

1.10

0.21

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

230

0.87

0.21

1.7

1.9

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

165.8

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.20

0.0

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.20

0.0

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

108

1.21

0.20

2.2

2.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.18

0.19

2.5

1.5

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.15

0.19

1.0

1.1

iu/ml

197.3

167.5

—

(3023419) Bacteria identified in Sputum by Culture

137

1.17

0.18

4.3

2.8

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.13

0.18

1.0

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

109

1.19

0.18

1.8

1.6

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

290

1.11

0.18

1.7

1.6

e6/l

256.8

990.9

0.74

237

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

290

1.11

0.18

1.6

e6/l

3.0

12.0

1.52

229

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

153

0.85

0.18

2.2

1.5

—

(40768806) Pleura Pathology biopsy report

1.22

0.17

1.9

1.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.73

0.17

1.0

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

0.77

0.15

3.0

2.1

—

1.7

—

(3011648) Oxygen content in Venous blood

1.21

0.15

2.5

5.6

14.0

10.7

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

207

1.11

0.15

1.1

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

113

1175

0.96

0.14

3.3

2.8

ug/l

0.9

0.8

0.21

724

(3043238) Trisomy 21 risk [Likelihood] in Fetus

401

1.07

0.14

1.4

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

139

1344

1.04

0.14

1.7

1.6

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

0.83

0.13

1.0

1.1

—

79.0

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

0.83

0.13

1.0

1.1

—

38.6

—

(3023410) Appearance of Cerebral spinal fluid

132

1.14

0.13

2.3

1.9

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

267

1.09

0.13

1.7

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

406

1.06

0.11

1.9

1.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

192

1.10

0.11

1.0

1.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

115

1.13

0.10

1.5

1.2

u/ml

0.2

0.7

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

125

1.12

0.10

3.1

3.8

—

(3035320) C reactive protein [Mass/volume] in Body fluid

1.15

0.09

2.0

2.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

116

1.12

0.09

2.5

2.0

nmol/l

25.7

22.0

0.31

109

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

155

0.90

0.09

2.1

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

126

1.11

0.09

1.0

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.81

0.08

1.0

1.3

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

0.79

0.08

1.0

1.5

—

77.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

154

0.91

0.08

2.1

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.86

0.07

1.0

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

266

0.94

0.07

1.1

u/ml

0.7

2.0

0.88

112

(3003888) Timothy IgE Ab [Units/volume] in Serum

276

0.94

0.07

1.1

u/ml

13.8

5.8

0.58

144

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

194

0.93

0.07

1.2

1.8

pmol/l

159.0

209.1

1.05

186

(3005988) Vibrio sp identified in Specimen by Organism specific culture

153

0.91

0.07

2.1

1.5

—

(3015183) Erythrocyte sedimentation rate

0.84

0.07

1.3

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

1.07

0.07

1.0

1.1

—

2.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.03

0.07

1.1

1.0

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

0.88

0.06

1.0

1.1

—

2.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

152

0.92

0.06

2.1

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

152

0.92

0.06

2.1

1.5

—

(3008037) Lactate [Moles/volume] in Venous blood

209

1.05

0.04

4.1

2.7

mmol/l

1.4

1.5

0.36

203

(3000093) Morphology [Interpretation] in Blood Narrative

1.09

0.03

1.0

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

521

0.98

0.03

1.4

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

108

0.93

0.03

1.4

1.5

—

(40761535) Cells panel - Urine sediment

918

1.01

0.02

3.0

3.1

—

(4146454)

103

1.07

0.02

2.1

2.7

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

213

1.03

0.01

1.3

1.1

iu/ml

36.8

2486.2

—

(3019225) pH of Specimen

115

1142

1.01

0.01

4.6

3.7

—

(40768800) Prostate Pathology biopsy report

126

1.03

0.00

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

144

0.97

0.00

1.8

1.6

43.9

57.1

—

101

(3004616) Nuclear Ab [Presence] in Serum

146

1.03

0.00

1.3

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

102

0.98

0.00

1.3

2.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

262

0.99

0.00

4.2

3.8

—

(4024509)

119

1.01

0.00

1.2

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

472

1.00

0.00

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

471

1.00

0.00

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

471

1.00

0.00

1.3

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

313

0.99

0.00

1.1

u/ml

0.2

2.2

2.04

122

(3044242) Glucose [Moles/volume] in Arterial blood

0.86

0.00

1.6

2.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.00

0.00

1.0

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3037756) Immunofixation for Serum or Plasma

220

1.00

0.00

1.6

1.7

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

0.00

0.0

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.0

2.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.98

0.00

1.4

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

7.8

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.98

0.00

1.7

1.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.95

0.00

1.0

1.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.98

0.00

1.7

1.6

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(4281824)

150

1.00

0.00

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.98

0.00

1.4

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.96

0.00

1.4

1.8

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

0.98

0.00

1.3

1.4

—

(3000012) Reticulocyte production index

0.94

0.00

1.5

1.4

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.0

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.96

0.00

1.4

1.8

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

20.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.96

0.00

1.4

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.96

0.00

1.4

1.8

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.1

—

7.8

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.0

5.6

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.0

1.0

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

0.0

1.9

—

172.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.98

0.00

1.2

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

0.98

0.00

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

470

1.00

0.00

1.3

1.4

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.0

1.0

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

34.5

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.0

1.0

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.98

0.00

1.7

1.6

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.2

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

2.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_SCARCONDITIONS and mortality.

Females

Parameter	HR [95% CI]	p-value
L12_SCARCONDITIONS	1.162 [1.0, 1.34]	0.043
Birth year	0.999 [0.99, 1.01]	0.85

During the follow-up period (1.1.1998 — 31.12.2019), 317 out of 4944 females with L12_SCARCONDITIONS died.

Males

Parameter	HR [95% CI]	p-value
L12_SCARCONDITIONS	1.13 [0.96, 1.34]	0.151
Birth year	0.987 [0.98, 1.0]	0.009

During the follow-up period (1.1.1998 — 31.12.2019), 246 out of 2379 males with L12_SCARCONDITIONS died.

Mortality risk

Mortality risk for people of age

years, who have L12_SCARCONDITIONS.

N-year risk	Females	Males
1	0.171%	0.243%
5	0.873%	1.446%
10	2.118%	3.502%
15	3.909%	6.488%
20	6.892%	10.721%

Relationships between endpoints

↥

Index endpoint: L12_SCARCONDITIONS – Scar conditions and fibrosis of skin

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Scar conditions and fibrosis of skin

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints